BioGeneration Ventures

General contacts
Investor type

PE / VC

Founded

2006

AUM

$100 M

Location

Naarden, North Holland, Netherlands

Investment Ticket

$0-1 m

Investment Stage

Seed Series A Series B

Region of investment

Europe
Investor profile last updated: 17 July, 2026

Profile

BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €100 million of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together.

BGV strives to work with founding teams to mature science and build companies. The Company uses its experience to guide progress into clinical trials, ultimately leading to successful drug development and value realisation for its investors. BGV applies its expertise in a rigorous process to select the most compelling opportunities with the best prospects for exit.

Historical successful investments include divestment of Dezima Pharma to Amgen for up to USD 1.55 billion in total deal value and in Acerta Pharma for up to USD 7 billion with a guaranteed payment of USD 4 billion. Both companies were co-founded by BGV in 2012 and 2013 respectively. The Acerta Pharma sale was the largest exit ever of a privately held European biotech company.

BGV is based in Naarden, The Netherlands, and closely collaborates with Forbion.

Industry

Biotechnology Life Sciences HealthTech Medical Devices MedTech

Contacts

Name
Title
Email
Social Networks
avatar
Edward Van Wezel Managing Partner
Managing Partner
-
LinkedIn
avatar
Keno Gutierrez Partner
Partner
-
LinkedIn
Upgrade to see contacts
avatar
n2zrSlOKVYNTmLU5 n2zrSlOKVYNTmLU5
n2zrSlOKVYNTmLU5
[email protected]
linkedin twitter
avatar
n2zrSlOKVYNTmLU5 n2zrSlOKVYNTmLU5
n2zrSlOKVYNTmLU5
[email protected]
linkedin twitter
avatar
n2zrSlOKVYNTmLU5 n2zrSlOKVYNTmLU5
n2zrSlOKVYNTmLU5
[email protected]
linkedin twitter
Investment-team contacts for BioGeneration Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about BioGeneration Ventures

BioGeneration Ventures is a venture capital and private equity firm. It backs companies at Seed, Series A and Series B, writing tickets of $0-1 m.
BioGeneration Ventures is located in Naarden, North Holland, Netherlands.
BioGeneration Ventures was founded in 2006.
BioGeneration Ventures invests in companies and startups in Biotechnology, Life Sciences, HealthTech, Medical Devices, MedTech.
BioGeneration Ventures invests in companies and startups in Europe.
BioGeneration Ventures invests in companies and startups at Seed, Series A, Series B.
BioGeneration Ventures usually invests $0-1 m on average.
BioGeneration Ventures has around $100m assets under management.
BioGeneration Ventures can be reached through its website biogenerationventures.com, its LinkedIn page and its X account. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for BioGeneration Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query BioGeneration Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 17 July, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.